Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal

Chemico-biological Interactions
Kwang-Youn KimYoung Woo Kim

Abstract

Deoxypodophyllotoxin (DPT) is a naturally occurring flavolignan in Anthriscus sylvestris known as cow parsley or wild chervil, and has been reported to have inhibitory effects against several pathological processes including cancer, inflammation and infection. Here, we report the effects of DPT in the fatty liver induced by high fat diet in vivo as well as its regulatory mechanism related with the transcription factor for lipogenic genes such as sterol regulatory element binding protein-1c (SREBP-1c) in vitro. C57BL/6 mice were fed high fat diet for 10 weeks and also orally administrated with DPT for additional 4 weeks. 5 and 10 mg/kg of DPT decreased lipid accumulation in the liver induced by high fat diet, as indicated by histological parameters such as Oil Red O staining and hematoxylin & eosin as well as the contents of hepatic triglyceride and cholesterol. In hepatocytes, DPT inhibited the liver X receptor α-mediated SREBP-1c induction and expression of the lipogenic genes, including fatty acid synthase, acetyl-CoA carboxylase and stearoyl-CoA desaturase-1. Moreover, DPT induced AMP-activated protein kinase (AMPK) activation, which has been known to inhibit the expression of SREBP-1c in hepatocyte. Also this compound resto...Continue Reading

References

Aug 28, 1999·Bioorganic & Medicinal Chemistry Letters·D SubrahmanyamD S Deevi
Jan 16, 2002·The Journal of Biological Chemistry·Sean B JosephPeter Tontonoz
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bryan A LaffittePeter Tontonoz
May 3, 2005·The Journal of Clinical Investigation·Kerry L DonnellyElizabeth J Parks
Nov 17, 2005·Annals of Internal Medicine·Masahide HamaguchiKazunori Ida
Mar 15, 2006·Journal of Hypertension·Panteleimon A Sarafidis, Peter M Nilsson
Jul 5, 2007·Journal of Gastroenterology and Hepatology·Shivakumar Chitturi, Geoffrey C Farrell
Jul 17, 2007·Molecular and Cellular Neurosciences·Anne-Sophie de PreuxRoman Chrast
Aug 11, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Anna Kotronen, Hannele Yki-Järvinen
Jan 26, 2008·Trends in Molecular Medicine·Fabio MarraClaudio Tiribelli
May 17, 2008·The Journal of Biological Chemistry·Xiuyun HouMengwei Zang
Aug 8, 2008·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Nobito HiguchiMunechika Enjoji
Oct 1, 2008·Progress in Lipid Research·Giovanni MussoMaurizio Cassader
Oct 31, 2008·Endocrine Reviews·Marc-Andre CornierRobert H Eckel
Dec 17, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Young Woo KimSang Geon Kim
May 7, 2009·Cell Metabolism·Bei B ZhangCai Li
Mar 12, 2010·Critical Reviews in Biochemistry and Molecular Biology·Maggie S Strable, James M Ntambi
Dec 18, 2010·Journal of Hepatology·Marc Foretz, Benoit Viollet
Jun 10, 2015·JAMA : the Journal of the American Medical Association·Mary E Rinella

❮ Previous
Next ❯

Citations

Dec 14, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tai-Mei DiXin-Fu Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.